AZN vs CMP · P/E 28, $288.38B cap vs rev $1.12B
AstraZeneca PLC (AZN) versus Compass Minerals International Inc (CMP) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Compass Minerals International Inc (CMP) is a other industrial metals & mining company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CMP revenue for 2024-09-30 was $1.12B. Net income was -$206.1M. Revenue was down 7.2% from 2023-09-30 to 2024-09-30. CMP currently screens at market cap $916.5M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CMP currently screens at market cap $916.5M.
Not investment advice. Open the AZN and CMP stock pages for the full models.
Not investment advice.